glp 1 and seizures Does tirzepatide (a dual GIP GLP-1 receptor agonist) increase the risk of seizures? GLP-1R Agonists for Weight Loss

He did this in collaboration with his Royal Free colleagues Maryanne Kuzio, Jill Drybrugh and Kathleen Malloy

Switching from Wegovy to Mounjaro Many patients choose to transition to Mounjaro to benefit from its dual-action GIP and GLP-1 receptor agonism

Provitalize and Pendulum both fall into this newer category

These results suggest there is no excess cardiovascular risk with tirzepatide and are consistent with the improvements of numerous surrogate markers of cardiovascular health, including weight reduction, glycemic control with less hypoglycemia, blood pressure reduction, and improvements in the lipid profile

An important consideration for patients of reproductive age is that Zepbound may reduce the effectiveness of oral contraceptives, particularly during initiation and dose escalation

doi: 10.4158/EP.13.4.345 9 Seng YueCBenvengaSScarsiCLopreteLDucharmeMP